Evidence map›Paper›PMID 38251252›Full record

ArticleToxins2024

The Chaperonin TRiC/CCT Inhibitor HSF1A Protects Cells from Intoxication with Pertussis Toxin.

Jinfang Jia, Manuel Zoeschg, Holger Barth, Arto T Pulliainen, Katharina Ernst

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxins, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Chaperonin in health and disease.Molecular biomedicine · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jinfang JiaInstitute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, 89081 Ulm, Germany.
Manuel ZoeschgInstitute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, 89081 Ulm, Germany.
Holger BarthInstitute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, 89081 Ulm, Germany.
Arto T PulliainenInstitute of Biomedicine, University of Turku, FI-20520 Turku, Finland.
Katharina ErnstInstitute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, 89081 Ulm, Germany.
Universität Ulm · DEUniversity of Turku · FI

Funding

Chinese Scholarship Council (CSC) IGradU Nanjing program (Medical Faculty of Ulm University, Southeast University (SEU) Nanjing ChinaEuropean Social Fund and Ministry of Science, Research and Art Baden-Württemberg Margarete von Wrangell Habilitation programUlm University Medical Faculty Hertha-Nathorff-Programm (Ergänzungsfinanzierung zu Margarete von Wrangell-Förderung)
6 · The paper itself

Abstract

Pertussis toxin (PT) is a bacterial AB

Indexed as

Bacterial ToxinsClostridioides difficileAntibodies, BacterialChaperonin Containing TCP-1CytosolPertussis ToxinAntibodies, BacterialBacterial ToxinsChaperonin Containing TCP-1Pertussis ToxinAB-type toxincellular uptakechaperoninpertussis toxintoxin inhibitorTRiC/CCT

Identifiers

PMID38251252
PMCPMC10819386
OpenAlexW4390702052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.